课题基金 / 基金详情

SPECIFIC GENETIC ANALYSIS OF PREMALIGNANT LESIONS OF THE PROSTATE USING SELECTIVE ULTRAVIOLET RADIATION FRACTIONATION TECHNIQUE

SPECIFIC GENETIC ANALYSIS OF PREMALIGNANT LESIONS OF THE PROSTATE USING SELECTIVE ULTRAVIOLET RADIATION FRACTIONATION TECHNIQUE
使用选择性紫外线辐射分割技术对前列腺癌前病变进行特异性基因分析
批准号:
07671710
负责人:
MATSUSHIMA Hisashi
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
目的:应用选择性紫外辐射分离技术检测苏木精伊红切片上组成PIN和腺癌的特定细胞p53抑癌基因的突变。材料与方法:回顾80例根治性前列腺切除术和20例尸检的HE切片,采用SURF法(Shibata, 1993)提取PIN、腺癌和高度前列腺增生的特异性DNA,采用聚合酶链反应扩增p53基因外显子4 ~ 9,单链构象多态性和直接测序检测突变。免疫组化法检测Ki-67、p53、bcl-2、p21(WAF!), TuUNEL法检测细胞凋亡。用CAS200计算机图像分析系统对结果进行定量评价。结果:前列腺基底细胞中检测到野生p53的表达,免疫阳性细胞数量随PIN分级的增加而减少。20%的腺癌中检测到P53核积累,12.5%的腺癌中检测到LOH。10%的PIN检出LOH。2例腺癌外显子4突变,6例外显子5突变,2例外显子7突变。低度PIN未见突变。10%的高级别PIN显示突变,所有这些突变都与腺癌同时发生,并且显示突变点与相关癌症的完美一致性。讨论:p53突变发生在小部分高级别PIN伴发腺癌患者中。然而,在无腺癌的PIN中未发现突变。考虑到这些因素,PIN中p53基因的改变可能是随后的事件,而不是前列腺癌发生的先决条件。
英文摘要
Objectives : To examine mutations of p53 tumor suppressor gene of specific cells constituting PIN and adenocarcinoma on hematoxylin eosin sections by selective ultraviolet radiation fractionation technique.Materials and Methods : Reviewing HE sections from 80 radical prostatectomies and 20 autopsies, DNA specific for PIN,adenocarcinoma and benigh prostatic hyperplasia was extracted by SURF method (Shibata, 1993) and exons 4 to 9 of p53 gene were amplified by polymerase chain reaction and mutations were examined by single strand conformation polymorphism and direct sequencing. Ki-67, p53, bcl-2 and p21(WAF! ) were detected by immunohistochemistry and apoptosis was detected by TuUNEL method. The results were quantitatively assessed by CAS200 computer image nalysis system.Results : Expression of wild p53 was detected in prostatic basal cells and the number of immunopositive cells decreased with advancing grade of PIN.P53 nuclear accumulation was detected in 20% of adenocarcinomas and LOH was detected in 12.5% of those. LOH was detected in 10% of PIN.Mutations of exon 4 in 2 adenocarcinomas, exon 5 in 6 and exon 7 in 2. There were no mutations found in low grade PIN.Ten percent of high grade PIN showed mutations all of which were concurrent with adenocarcinomas and showed a perfect concordance of mutation point with associated cancer.Discussion : Mutations of p53 occurrs in a small subset of high grade PIN accompanying adenocarcinoma. However, there was no mutation found in PIN without adenocacinoma. Taking these into consideration, p53 gene alteration in PIN may be asubsequent event rather than a antecedant to prostatic carcinogenesis.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Suzuki M,Matsushima,H et al.: "Nuclear DNA ploidy of testisular tumors." Urol.Int.57. 203-208 (1996)
Suzuki M、Matsushima、H 等人:“睾丸肿瘤的核 DNA 倍性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsushima,H,et al: "Bcl-2 expression in prostate cencer and its relationship to cell cycle and prognosis" International Journel of Urology. 3. (in press) (1996)
Matsushima,H,et al:“前列腺癌中的 Bcl-2 表达及其与细胞周期和预后的关系”国际泌尿学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsushima, H et al: "Cowbined analysis with bcl-2 and p53 immuno staining predicts poorer progrosis in prostatic carcinowa." J.Urol.158. 2278-2283 (1997)
Matsushima, H 等人:“bcl-2 和 p53 免疫染色的 Cowbined 分析预测前列腺癌的进展较差。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsushima,H et al: "Immunohistochemical study of p21 WAF1 and p53 proteins in Prostatic cancer and its prognostui significance" Human Pathology(in press). 29. (1998)
Matsushima,H 等人:“前列腺癌中 p21 WAF1 和 p53 蛋白的免疫组织化学研究及其预后意义”《人类病理学》(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 26 条
    国内基金
    海外基金
    用于航天的集成式自驱动硅PIN探测器关键技术与性能优化
    • 批准号:
      2026JJ50498
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      朱智源
    • 依托单位:
    靶向Pin1改善MSS型结直肠癌免疫抑制微环境的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      吴春蓉
    • 依托单位:
    堆叠式硅PIN辐射探测器
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      朱智源
    • 依托单位:
    传统宽PIN距NTC热敏元件智能制造升级与国产化关键技术研究